BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37976817)

  • 1. Methods, bioinformatics tools and databases in ecDNA research: An overview.
    Zhao X; Zhao H; Liu Y; Guo Z
    Comput Biol Med; 2023 Dec; 167():107680. PubMed ID: 37976817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy.
    Li Z; Wang B; Liang H; Han L
    Int J Biol Sci; 2022; 18(10):4006-4025. PubMed ID: 35844796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrachromosomal DNA in Cancer.
    Bafna V; Mischel PS
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():29-52. PubMed ID: 35609926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrachromosomal DNA: An Emerging Hallmark in Human Cancer.
    Wu S; Bafna V; Chang HY; Mischel PS
    Annu Rev Pathol; 2022 Jan; 17():367-386. PubMed ID: 34752712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers.
    Kim H; Nguyen NP; Turner K; Wu S; Gujar AD; Luebeck J; Liu J; Deshpande V; Rajkumar U; Namburi S; Amin SB; Yi E; Menghi F; Schulte JH; Henssen AG; Chang HY; Beck CR; Mischel PS; Bafna V; Verhaak RGW
    Nat Genet; 2020 Sep; 52(9):891-897. PubMed ID: 32807987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into extrachromosomal DNA: redefining the onco-drivers of tumor progression.
    Gu X; Yu J; Chai P; Ge S; Fan X
    J Exp Clin Cancer Res; 2020 Oct; 39(1):215. PubMed ID: 33046109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrachromosomal DNA in cancer.
    Yan X; Mischel P; Chang H
    Nat Rev Cancer; 2024 Apr; 24(4):261-273. PubMed ID: 38409389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The formation mechanism and homeostasis of extrachromosomal DNA.
    Tao Y; Ning Q; Wang Z; Tang N; Zhao X; Tang S
    Carcinogenesis; 2022 Oct; 43(9):815-825. PubMed ID: 36037043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance.
    Pecorino LT; Verhaak RGW; Henssen A; Mischel PS
    Biochem Soc Trans; 2022 Dec; 50(6):1911-1920. PubMed ID: 36355400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.
    Chapman OS; Luebeck J; Sridhar S; Wong IT; Dixit D; Wang S; Prasad G; Rajkumar U; Pagadala MS; Larson JD; He BJ; Hung KL; Lange JT; Dehkordi SR; Chandran S; Adam M; Morgan L; Wani S; Tiwari A; Guccione C; Lin Y; Dutta A; Lo YY; Juarez E; Robinson JT; Korshunov A; Michaels JA; Cho YJ; Malicki DM; Coufal NG; Levy ML; Hobbs C; Scheuermann RH; Crawford JR; Pomeroy SL; Rich JN; Zhang X; Chang HY; Dixon JR; Bagchi A; Deshpande AJ; Carter H; Fraenkel E; Mischel PS; Wechsler-Reya RJ; Bafna V; Mesirov JP; Chavez L
    Nat Genet; 2023 Dec; 55(12):2189-2199. PubMed ID: 37945900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolutionary dynamics of extrachromosomal DNA in human cancers.
    Lange JT; Rose JC; Chen CY; Pichugin Y; Xie L; Tang J; Hung KL; Yost KE; Shi Q; Erb ML; Rajkumar U; Wu S; Taschner-Mandl S; Bernkopf M; Swanton C; Liu Z; Huang W; Chang HY; Bafna V; Henssen AG; Werner B; Mischel PS
    Nat Genet; 2022 Oct; 54(10):1527-1533. PubMed ID: 36123406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.
    van Leen E; Brückner L; Henssen AG
    Nat Genet; 2022 Feb; 54(2):107-114. PubMed ID: 35145302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrachromosomal DNA (ecDNA): Unveiling its role in cancer progression and implications for early detection.
    Wu S; Tao T; Zhang L; Zhu X; Zhou X
    Heliyon; 2023 Nov; 9(11):e21327. PubMed ID: 38027570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrachromosomal DNA (ecDNA) in cancer pathogenesis.
    Wu S; Bafna V; Mischel PS
    Curr Opin Genet Dev; 2021 Feb; 66():78-82. PubMed ID: 33477016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular ecDNA promotes accessible chromatin and high oncogene expression.
    Wu S; Turner KM; Nguyen N; Raviram R; Erb M; Santini J; Luebeck J; Rajkumar U; Diao Y; Li B; Zhang W; Jameson N; Corces MR; Granja JM; Chen X; Coruh C; Abnousi A; Houston J; Ye Z; Hu R; Yu M; Kim H; Law JA; Verhaak RGW; Hu M; Furnari FB; Chang HY; Ren B; Bafna V; Mischel PS
    Nature; 2019 Nov; 575(7784):699-703. PubMed ID: 31748743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATACAmp: a tool for detecting ecDNA/HSRs from bulk and single-cell ATAC-seq data.
    Cheng H; Ma W; Wang K; Chu H; Bao G; Liao Y; Yuan Y; Gou Y; Dong L; Yang J; Cai H
    BMC Genomics; 2023 Nov; 24(1):678. PubMed ID: 37950200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guilt by association: EcDNA as a mobile transactivator in cancer.
    Zhu Y; Gong L; Wei CL
    Trends Cancer; 2022 Sep; 8(9):747-758. PubMed ID: 35753910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking the vicious circle: Extrachromosomal circular DNA as an emerging player in tumour evolution.
    Robert M; Crasta K
    Semin Cell Dev Biol; 2022 Mar; 123():140-150. PubMed ID: 34857471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression.
    Liao Z; Jiang W; Ye L; Li T; Yu X; Liu L
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188392. PubMed ID: 32735964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress on the role of extrachromosomal DNA in tumor pathogenesis and evolution.
    Xing J; Ning Q; Tang D; Mo Z; Lei X; Tang S
    Clin Genet; 2021 Apr; 99(4):503-512. PubMed ID: 33314031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.